Viewing Study NCT07193420

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:16 AM
Ignite Modification Date: 2026-07-02 @ 5:33 AM
Study NCT ID: NCT07193420
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-25
First Post: 2025-07-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None GVHD - Graft-Versus-Host Disease View
None HSCT View
None Haploidentical Stem Cell Transplantation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cyclophosphamide toxicities View
None Cyclophosphamide dose reduction View
None Graft-Versus-Host Disease: GVHD View
None Hematopoietic stem cell transplantation View